发明名称 |
Single Dose Oral Formulations and Methods for Treatment of Cats with Ectoparasiticidal Spinosad |
摘要 |
This invention provides a single-dose oral formulation of spinosad for the extended control of a C. felis infestation on a cat at a predictable dose of spinosad that is suitable for administration once every 30 days (i.e., one month). The invention also provides methods of using the formulation of spinosad. |
申请公布号 |
US2016101127(A1) |
申请公布日期 |
2016.04.14 |
申请号 |
US201514974961 |
申请日期 |
2015.12.18 |
申请人 |
Eli Lilly and Company |
发明人 |
Riggs Kari Lynette;Snyder Daniel Earl;Totten Michelle Leigh |
分类号 |
A61K31/7048;A23K1/16;A61K9/20;A23K1/18;A61K9/00;A61K9/48 |
主分类号 |
A61K31/7048 |
代理机构 |
|
代理人 |
|
主权项 |
1. A single-dose oral formulation for controlling a C. felis infestation on a cat comprising an ectoparasiticidal amount of spinosad, microcrystalline cellulose, hydroxypropylcellulose, colloidal silicon (anhydrous), croscarmellose sodium, and magnesium stearate, and optionally an artificial flavor, wherein the formulation is suitable for oral administration once every 30 days at a dose of at least about 50 mg of spinosad per kg of body weight of the cat. |
地址 |
Indianapolis IN US |